LIEBEL-FLARSHEIM FDA Approval NDA 013295

NDA 013295

LIEBEL-FLARSHEIM

FDA Drug Application

Application #013295

Documents

Letter2003-06-22
Letter2014-07-10
Letter2015-07-10
Label2015-07-09
Label2017-04-06
Letter2017-04-12
Letter2022-02-22
Label2022-02-23

Application Sponsors

NDA 013295LIEBEL-FLARSHEIM

Marketing Status

Prescription001
Discontinued002

Application Products

001INJECTABLE;INJECTION60%1CONRAYIOTHALAMATE MEGLUMINE
002INJECTABLE;INJECTION43%1CONRAY 43IOTHALAMATE MEGLUMINE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1962-08-16PRIORITY
LABELING; LabelingSUPPL13AP1975-08-22
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1975-07-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1976-01-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1976-01-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1976-05-06PRIORITY
LABELING; LabelingSUPPL24AP1976-05-05
LABELING; LabelingSUPPL25AP1978-10-17
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1978-10-17PRIORITY
EFFICACY; EfficacySUPPL27AP1978-10-17
MANUF (CMC); Manufacturing (CMC)SUPPL28AP1978-10-17PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL29AP1978-08-29PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1978-10-20PRIORITY
EFFICACY; EfficacySUPPL31AP1982-10-20
LABELING; LabelingSUPPL32AP1979-12-07
EFFICACY; EfficacySUPPL33AP1983-01-26
LABELING; LabelingSUPPL34AP1983-02-25
LABELING; LabelingSUPPL36AP1983-01-26
LABELING; LabelingSUPPL38AP1982-10-22
MANUF (CMC); Manufacturing (CMC)SUPPL39AP1982-10-20PRIORITY
LABELING; LabelingSUPPL40AP1984-06-19
MANUF (CMC); Manufacturing (CMC)SUPPL41AP1984-06-25PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL42AP1984-12-04PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL43AP1989-10-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL44AP1989-06-28PRIORITY
LABELING; LabelingSUPPL45AP1984-09-12
LABELING; LabelingSUPPL46AP1984-10-25
EFFICACY; EfficacySUPPL47AP1985-09-09
MANUF (CMC); Manufacturing (CMC)SUPPL48AP1985-04-08PRIORITY
LABELING; LabelingSUPPL49AP1986-12-18
MANUF (CMC); Manufacturing (CMC)SUPPL50AP1989-10-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL51AP1988-08-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL52AP1989-12-01PRIORITY
LABELING; LabelingSUPPL53AP1989-06-28
MANUF (CMC); Manufacturing (CMC)SUPPL54AP1990-03-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL55AP1992-12-04PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL56AP1992-08-28PRIORITY
LABELING; LabelingSUPPL57AP1995-01-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL58AP1999-10-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL59AP2001-02-26PRIORITY
LABELING; LabelingSUPPL60AP2003-06-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL61AP2013-05-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL62AP2013-05-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL63AP2013-07-23PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL64AP2013-12-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL65AP2014-02-25PRIORITY
LABELING; LabelingSUPPL66AP2014-07-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL67AP2015-02-03PRIORITY
LABELING; LabelingSUPPL68AP2015-07-06901 REQUIRED
MANUF (CMC); Manufacturing (CMC)SUPPL69AP2016-06-22PRIORITY
LABELING; LabelingSUPPL70AP2017-04-05STANDARD
LABELING; LabelingSUPPL72AP2022-02-18STANDARD

Submissions Property Types

SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL26Null0
SUPPL28Null0
SUPPL29Null0
SUPPL30Null0
SUPPL39Null0
SUPPL41Null0
SUPPL42Null0
SUPPL43Null0
SUPPL44Null0
SUPPL48Null0
SUPPL50Null0
SUPPL51Null0
SUPPL52Null0
SUPPL54Null0
SUPPL55Null0
SUPPL56Null0
SUPPL58Null0
SUPPL59Null0
SUPPL61Null0
SUPPL62Null0
SUPPL63Null0
SUPPL64Null0
SUPPL65Null0
SUPPL66Null15
SUPPL67Null0
SUPPL68Null6
SUPPL69Null0
SUPPL70Null15
SUPPL72Null15

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 13295
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.